Publications by authors named "Jonathan D Spicer"

Claim this Profile
N
Neoadjuvant Chemoimmunotherapy.
Gökce Yavuz, Jonathan D Spicer

Thorac Surg Clin· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Architecture of the neutrophil compartment.
Daniela Cerezo-Wallis, Andrea Rubio-Ponce, Mathis Richter, Emanuele Pitino, Immanuel Kwok, Jonathan D Spicer

Nature· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671.
Moishe Liberman, David R Jones, Heather Wakelee, Shugeng Gao, Balazs Halmos, Jonathan D Spicer

Ann Thorac Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil extracellular traps in cancer.
Muhammad H Shahzad, Roni F Rayes, Jonathan Cools-Lartigue, Jonathan D Spicer

Nat Rev Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of lobar versus sublobar video-assisted thoracoscopic surgery lung resection on patient quality of life.
Lyndon C Walsh, Joseph Seitlinger, Morgan S Gold, Mark Sorin, Francesca Fermi, Jonathan D Spicer

J Thorac Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?
Joseph Seitlinger, Olivier Salko, Luciano Bulgarelli Maqueda, Andrew Meng, Maxime Têtu, Jonathan D Spicer

Ann Thorac Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma.
Meghan L De Meo, Joseph Seitlinger, Roni F Rayes, Lyndon C Walsh, Muhammad H Shahzad, Jonathan D Spicer

Clin Lung Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.
Patrick M Forde, Jonathan D Spicer, Mariano Provencio, Tetsuya Mitsudomi, Mark M Awad

N Engl J Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VALUE Trial: Phase 1 safety and feasibility study of same-day discharge after video-assisted thoracoscopic surgery lung resection.
Lyndon C Walsh, Merav Rokah, Joseph Seitlinger, Filippo Tommaso Gallina, Caroline Huynh, Jonathan D Spicer

J Thorac Cardiovasc Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung metastases.
Lodovica Zullo, Dimitris Filippiadis, Lizza E L Hendriks, Daniel Portik, Jonathan D Spicer

Nat Rev Dis Primers· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Tension Chyle Leak": A Life-Threatening Sequela of Thoracic Duct Injury Following Resection of BRAF-Mutated Anaplastic Thyroid Carcinoma.
Karim Botros, Khashayar Esfahani, Khalil Sultanem, Jonathan D Spicer, Alex A Mlynarek

Head Neck· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveying surgeon practices and perspectives on extent of intraoperative nodal evaluation in non-small cell lung cancer.
Lyndon C Walsh, Alessandro Brunelli, Biniam Kidane, Jazmin Eckhaus, Pierre Olivier Fiset, Jonathan D Spicer

JTCVS Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatially mapping the tumour immune microenvironments of non-small cell lung cancer.
Lysanne Desharnais, Mark Sorin, Morteza Rezanejad, Bridget Liu, Elham Karimi, Jonathan D Spicer

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Immunotherapy for Node-Negative Non-Small Cell Lung Cancer-Current Evidence and Future Directions.
Muhammad H Shahzad, Jonathan D Spicer, Valerie W Rusch, Peter J Kneuertz

Ann Thorac Surg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why and When Do We Invasively Restage After Neoadjuvant Chemoimmunotherapy?
Jonathan D Spicer, Tina Cascone, Murry W Wynes, Karen L Kelly

J Thorac Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer-Reply.
Mark Sorin, Connor Prosty, Jonathan D Spicer

JAMA Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum.
Parneet K Cheema, Paul F Wheatley-Price, Matthew J Cecchini, Peter M Ellis, Alexander V Louie, Jonathan D Spicer

Curr Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer.
Jonathan D Spicer, Tina Cascone, Murry W Wynes, Myung-Ju Ahn, Sanja Dacic

J Thorac Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non-small cell lung cancer.
Barbara Melosky, Mark D Vincent, Anna L McGuire, Anthony M Brade, Quincy Chu, Jonathan D Spicer

Int J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB-IIIB NSCLC.
Martin Reck, Ernest Nadal, Nicolas Girard, Andrea R Filippi, Linda W Martin, Jonathan D Spicer

Clin Lung Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.
Jonathan D Spicer, Marina C Garassino, Heather Wakelee, Moishe Liberman, Terufumi Kato

Lancet· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Nivolumab in Resectable Lung Cancer. Reply.
Tina Cascone, Jonathan D Spicer, Mariano Provencio Pulla

N Engl J Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
Yohann Pilon, Merav Rokah, Joseph Seitlinger, Boris Sepesi, Roni F Rayes, Jonathan D Spicer

Clin Lung Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis.
Mark Sorin, Connor Prosty, Louis Ghaleb, Kathy Nie, Khaled Katergi, Jonathan D Spicer

JAMA Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Nivolumab in Resectable Lung Cancer.
Tina Cascone, Mark M Awad, Jonathan D Spicer, Jie He, Shun Lu

N Engl J Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis